Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 919-274-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
The genotoxic potential of the substance was investigated in fully compliant in vitro (gene mutation in bacterial cells and chromosome aberration assay) and in vivo (micronucleus) studies.
In the Ames test both Salmonella typhimurium and Escherichia coli strains were used. The test substance was tested up to the limit dose of 5000 µg/plate, a concentration at which precipitation occurred but not precluded the evaluation, both in the absence and the presence of metabolic activation. The results of the study were negative.
Similarly, in a chromosome aberration assay using cultured human peripheral blood lymphocytes performed up to concentrations causing reductions in the mitotic index and/or precipitation (i.e. 1stexperiment: without metabolic activation the concentration of 432 µg/mL had a precipitate at the end of the treatment period and a 49% reduction in mitotic index; with metabolic activation the concentration of 432 µg/mL had a precipitate at the end of the treatment period and a 30% reduction in mitotic index; 2ndexperiment: without metabolic activation the concentration of 203 µg/mL had a 54% reduction in mitotic index; with metabolic activation the concentration of 450 µg/mL had a precipitate at the end of the treatment period and a 51% reduction in mitotic index), results were negative.
In an in vivo micronucleus test, the substance was injected intraperitoneally to male mice, to allow maximal delivery to the test system, up to the dosage of 100 mg/kg bw that was considered to be the maximum tolerated dose (MTD) on the basis of a range-finding test. Hunched posture was noted in 1 and 2 of the 7 male mice treated at the MTD, 24 and 48 hrs following dosing, respectively. In addition, although not statistically significant, all treated groups had PCE/NCE ratios lower than their concurrent vehicle controls. These observations indicate that systemic absorption had occurred, and exposure of the target organ achieved. Under these conditions, the substance was negative for micronuclei formation.
Short description of key information:
The following information is available for the genetic toxicity endpoints:
Thompson P.W. (2007) AS305BD: Salmonella typhimurium and Escherichia coli/mammalian-microsome reverse mutation assay. Testing laboratory: Safepharm Laboratories Limited. Report no.: 0703-0380. Owner company: Chevron Energy Technology Company. Report date: 2007-10-08.
Murli H. (2007) Chromosomal Aberrations in Cultured Human Peripheral Blood Lymphocytes. Testing laboratory: Covance Laboratories Inc. Report no.: 6183-144. Owner company: Chevron Energy Technology Company. Report date: 2007-11-16.
Duward R. & Flanders L. (2007) AS305BD: Micronucleus test in the mouse. Testing laboratory: Safepharm Laboratories Limited. Report no.: 0703/0381. Owner company: Chevron Energy Technology Company. Report date: 2007-09-20.
These studies have been rated as 1 under the Klimisch scoring system and so are considered to be sufficient to address these endpoints.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.